On Mounjaro or Zepbound? Your Birth Control Needs a Backup for 4 Weeks
Author
Date Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link
If you take tirzepatide and the birth control pill, the label says to add a barrier method or switch to a non-oral method for 4 weeks after you start and 4 weeks after every dose increase. For many current patients taking these medications, that’s news to them. The part that also surprises people: semaglutide doesn't carry this warning. Which medicine you're on genuinely changes the answer.
Who This Helps
This is for you if you take an oral contraceptive pill and you're starting, or already on, a GLP-1. It's a five minute conversation with your prescriber that nobody seems to have, and much easier to have before you need it than after.
Tirzepatide has the warning. Semaglutide does not.
This is the bit most coverage smudges, so let's be precise about it.
- Tirzepatide, sold as Mounjaro and Zepbound: carries the warning. 4 weeks after starting, 4 weeks after each dose increase (Mounjaro prescribing information) (Zepbound prescribing information).
- Orforglipron, sold as Foundayo: carries a similar warning, and the label says 30 days rather than 4 weeks (Foundayo prescribing information).
- Semaglutide, sold as Ozempic, Wegovy and Rybelsus: no such warning. The Wegovy label reports "no clinically significant differences" in how the body handles ethinyl estradiol and levonorgestrel alongside semaglutide (Wegovy prescribing information).
The Mounjaro label puts it more clearly than any paraphrase: "Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method or add a barrier method of contraception for 4 weeks after initiation and for 4 weeks after each dose escalation with MOUNJARO" (Mounjaro prescribing information). The Zepbound label carries a nearly identical instruction.
Why it happens, and why it fades
These medicines slow down how fast your stomach empties. That's part of how they work, and it's also why a pill you swallow can sit around longer and get absorbed less completely.
The label explains it in one line: use of tirzepatide "may reduce the efficacy of oral hormonal contraceptives due to delayed gastric emptying. This delay is largest after the first dose and diminishes over time" (Mounjaro prescribing information).
The study behind that is short and useful. After a single 5 mg dose of tirzepatide alongside a combined pill, peak levels of the three hormones dropped by 59%, 66% and 55%, and total exposure across the day dropped by 20% to 23%. That's a big dip at the peak and a smaller one across the whole day, and it's largest right at the start. Which is exactly why the advice is to switch to a temporary backup rather than a permanent change.
One genuinely reassuring detail: methods that don't go through your stomach aren't affected. The label says so directly, that "hormonal contraceptives that are not administered orally should not be affected." So the implant, the IUD, the shot, the patch and the ring all sit this one out.
Find a provider in your state
Answer a few questions and see live pricing from the providers that ship where you live.
The other half of the story is that fertility can pick up
Weight loss can restart ovulation in people whose cycles had stopped, and that catches people off guard. In a 2026 study of patients with PMOS, formerly called PCOS, 42 of the 80 who weren't ovulating at the start were ovulating again after six months on semaglutide, which is 52.5% (Journal of Clinical Medicine). That study had no comparison group and no placebo arm, so treat the number as a direction of travel rather than a precise figure.
Put the two things together and you can see the situation. Your cycle may be returning at the same moment your pill is working less predictably. Neither of those is a problem on its own. Together they're worth a plan.
If pregnancy is something you're planning rather than avoiding, that's a different conversation with different timing. The Wegovy label tells people to stop at least 2 months before trying to conceive, because semaglutide stays in the body a long while (Wegovy prescribing information). The tirzepatide labels don't carry that same two-month instruction, so ask rather than assume the rule is the same.
What to actually do about it
- Ask which medicine you're on, by ingredient. Brand names travel, ingredients decide. Tirzepatide and orforglipron, yes. Semaglutide, no.
- Time the backup to the changes. Starting and every dose increase are the moments, not the whole course of treatment.
- Consider whether switching methods is simpler. If your dose is going up every four weeks for a few months, a non-oral method may save you tracking it.
- If you've been vomiting, treat that separately. A pill that comes back up wasn't absorbed. That isn't in the label, it's just how pills work, and it applies whichever GLP-1 you take.
This isn't only about birth control, either. Slower stomach emptying can affect other swallowed medicines, and the labels flag drugs where the exact level matters, like warfarin. Be sure to share all your medications with your clinician so they can advise you accordingly, and if you start taking a new medication let that new prescribing clinician know if you’re on a GLP-1 (Mounjaro prescribing information).
Final Takeaway
This is one of those things that's easy to handle and easy to miss entirely. If you're on tirzepatide or orforglipron and you take the pill, use a backup for the first four weeks and after each dose bump, or talk about switching to something that doesn't rely on your stomach. If you're on semaglutide, the label doesn't ask you to change anything. Either way, tell your prescriber what you're using so they can tell you what applies to you. It's a short question with a clear answer, and it's much nicer to ask now than to wonder later.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Frequently Asked Questions
Does Ozempic or Wegovy make the birth control pill less effective?
The labels don't say so. The Wegovy label reports no clinically significant difference in how the body handles the hormones in a combined pill when taken alongside semaglutide. The warning about oral contraceptives applies to tirzepatide and to orforglipron, not to semaglutide.
Does this affect the IUD, implant, patch or ring?
No. The tirzepatide label states that hormonal contraceptives not taken by mouth should not be affected, because the issue is absorption from the stomach. Anything that bypasses your digestive system sidesteps it.
How long do I need a backup method?
For tirzepatide, 4 weeks after you start and 4 weeks after each dose increase. For orforglipron the label says 30 days for the same two situations. Once you're settled at a steady dose and past that window, the label doesn't ask for ongoing backup.
Find a provider in your state
Answer a few questions and see live pricing from the providers that ship where you live.
Sources
Keep Reading
SB 1089 passed the California Legislature and awaits the governor. See what it actually does, what it does not do, and what to watch next.
PCOS was renamed PMOS in 2026. See what the pooled randomized evidence on GLP-1s actually found, and why a PMOS diagnosis will not unlock coverage.
Turnkey platforms let almost anyone launch a GLP-1 clinic, one vendor says daily. See why prices fell, where the risk sits, and the 3 names to ask for
Categories
Written by
Lauren PescarusLauren Pescarus is a team member with GLP Winner where she works on marketing, content creation, and operations. She has over 10 years experience in the content creation space, including in the GLP-1 space where she works to stay on top of access news, research updates, and lifestyle tips guided by science.